American Biotechnology Co

Company Information

Company Name
American Biotechnology Co
Address
7658 Standish Pl - Ste 107
Rockville, MD, 20855
Phone
n/a
URL
n/a
DUNS
n/a
Number of Employees
10
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$248,122.00
5
SBIR Phase II
$495,000.00
1
Chart code to be here

Award List

  1. THE GOAL OF THIS PROJECT WILL BE TO SCREEN NEW DERIVATIVES OF L-ASCORBIC ACID ADDUCTS CLASSIFIED AS METHYLFURYLBUTYROLACTONES, ALSO REFERRED TO AS NAFOCARE B.

    Amount: $50,000.00

    THE GOAL OF THIS PROJECT WILL BE TO SCREEN NEW DERIVATIVES OF L-ASCORBIC ACID ADDUCTS CLASSIFIED AS METHYLFURYLBUTYROLACTONES, ALSO REFERRED TO AS NAFOCARE B. WORKING IN COLLABORATION WITH A SYNTHETIC ...

    SBIR Phase I 1985 Department of Health and Human Services
  2. AND ITS POTENTIAL APPLICATION TO HUMAN HYBRIDOMA TECHNOLOGY.

    Amount: $49,593.00

    AND ITS POTENTIAL APPLICATION TO HUMAN HYBRIDOMA TECHNOLOGY.THIS PROJECT INVOLVES DETERMINING THE ABILITY OF A NEW CLASS OF SYNTHETIC BIOLOGICAL RESPONSE MODIFIERS (BRM) KNOWN AS METHYLFURYLBUTYROLACT ...

    SBIR Phase I 1985 Department of Health and Human Services
  3. ALTHOUGH INVESTIGATION INTO BIOLOGICAL RESPONSE MODIFIERS HAS INCREASED RECENTLY, MOST OF THE EFFORT HAS BEEN TOWARDS POTENTIATING THE HOST'S CELL-MEDIATED IMMUNITY.

    Amount: $48,529.00

    ALTHOUGH INVESTIGATION INTO BIOLOGICAL RESPONSE MODIFIERS HAS INCREASED RECENTLY, MOST OF THE EFFORT HAS BEEN TOWARDS POTENTIATING THE HOST'S CELL-MEDIATED IMMUNITY. DATA ACCUMULATED BY OUR LABORATORI ...

    SBIR Phase I 1985 Department of Health and Human Services
  4. INTERFACE

    Amount: $50,000.00

    A MAJOR OBJECTIVE OF THIS STUDY IS TO INVESTIGATE THE UTILITY OF A NEW AND INNOVATIVE LIQUID MICROCARRIER (MC) SYSTEM FOR CLONING AND PROPAGATING HUMAN TUMOR CELLS IN VITRO. THIS NEW PATENTED TECHNOLO ...

    SBIR Phase I 1986 Department of Health and Human Services
  5. EVALUATION OF THE IMMUNE MODULATOR MFBL FOR ANTIVIRAL EFFICACY

    Amount: $495,000.00

    THE METHYLFURYLBUTYROLACTONES (MFBL'S) ARE A UNIQUE GROUP OF CHEMICAL COMPOUNDS THAT COMPRISE A NEW GROUP OF SYNTHETIC IMMUNOMODULATORS. THE COMPOUNDS ARE WATER SOLUBLE, RELATIVELY NON-TOXIC, ECONOMIC ...

    SBIR Phase II 1988 NavyDepartment of Defense
  6. EVALUATION OF THE IMMUNE MODULATOR MFBL FOR ANTIVIRAL EFFICACY

    Amount: $50,000.00

    N/A

    SBIR Phase I 1987 NavyDepartment of Defense

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government